130 related articles for article (PubMed ID: 23255431)
1. Developing proteomics-based biomarkers for colorectal neoplasms for clinical practice: opportunities and challenges.
Luo Y; Wang L; Wang J
Proteomics Clin Appl; 2013 Jan; 7(1-2):30-41. PubMed ID: 23255431
[TBL] [Abstract][Full Text] [Related]
2. Quantitative mass spectrometry for colorectal cancer proteomics.
Martínez-Aguilar J; Chik J; Nicholson J; Semaan C; McKay MJ; Molloy MP
Proteomics Clin Appl; 2013 Jan; 7(1-2):42-54. PubMed ID: 23027722
[TBL] [Abstract][Full Text] [Related]
3. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
[TBL] [Abstract][Full Text] [Related]
4. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
de Wit M; Jimenez CR; Carvalho B; Belien JA; Delis-van Diemen PM; Mongera S; Piersma SR; Vikas M; Navani S; Pontén F; Meijer GA; Fijneman RJ
Gut; 2012 Jun; 61(6):855-64. PubMed ID: 21890811
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer proteomics, molecular characterization and biomarker discovery.
Barderas R; Babel I; Casal JI
Proteomics Clin Appl; 2010 Feb; 4(2):159-78. PubMed ID: 21137041
[TBL] [Abstract][Full Text] [Related]
6. The discovery and validation of colorectal cancer biomarkers.
Ang CS; Phung J; Nice EC
Biomed Chromatogr; 2011 Jan; 25(1-2):82-99. PubMed ID: 21058408
[TBL] [Abstract][Full Text] [Related]
7. Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.
Wang K; Huang C; Nice EC
Expert Rev Proteomics; 2014 Apr; 11(2):179-205. PubMed ID: 24611605
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic biomarkers in colorectal cancer diagnostics.
Rawson JB; Bapat B
Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
[TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
10. Cancer. Developing molecular biomarkers for cancer.
Ransohoff DF
Science; 2003 Mar; 299(5613):1679-80. PubMed ID: 12637728
[No Abstract] [Full Text] [Related]
11. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic biomarkers of colorectal cancer.
Choong MK; Tsafnat G
Clin Gastroenterol Hepatol; 2012 Jan; 10(1):9-15. PubMed ID: 21635968
[TBL] [Abstract][Full Text] [Related]
13. Novel prognostic biomarkers in colorectal cancer.
Malesci A; Laghi L
Dig Dis; 2012; 30(3):296-303. PubMed ID: 22722555
[TBL] [Abstract][Full Text] [Related]
14. Cancer biomarkers: knowing the present and predicting the future.
Chatterjee SK; Zetter BR
Future Oncol; 2005 Feb; 1(1):37-50. PubMed ID: 16555974
[TBL] [Abstract][Full Text] [Related]
15. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist.
Søreide K; Nedrebø BS; Knapp JC; Glomsaker TB; Søreide JA; Kørner H
Surg Oncol; 2009 Mar; 18(1):31-50. PubMed ID: 18672360
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
Ma H; Chen G; Guo M
Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
[TBL] [Abstract][Full Text] [Related]
17. Identification of biomarkers for colorectal cancer through proteomics-based approaches.
Tjalsma H
Expert Rev Proteomics; 2010 Dec; 7(6):879-95. PubMed ID: 21142889
[TBL] [Abstract][Full Text] [Related]
18. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
[TBL] [Abstract][Full Text] [Related]
19. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?
Reumer A; Maes E; Mertens I; Cho WC; Landuyt B; Valkenborg D; Schoofs L; Baggerman G
Expert Rev Proteomics; 2014 Aug; 11(4):449-63. PubMed ID: 24702250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
